DelveInsight's Complex Regional Pain Syndrome (CRPS) - Epidemiology Forecast 2032 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Complex Regional Pain Syndrome (CRPS) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Complex Regional Pain Syndrome Epidemiology Insights Report

DelveInsight's "Complex Regional Pain Syndrome (CRPS)- Epidemiology Forecast-2034" report delivers an in-depth understanding of the CRPS, historical and forecasted epidemiology as well as the CRPS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
<h2>Geography Covered</h2>
<ul>
<li>The United States</li>
<li>EU4 (Germany, France, Italy, and Spain) and the United Kingdom</li>
<li>Japan</li>
</ul>
Study Period: 2021-2034
<h2>Complex Regional Pain Syndrome (CRPS) Understanding</h2>
The DelveInsight&rsquo;s Complex Regional Pain Syndrome epidemiology report gives a thorough understanding of the CRPS, which is a broad term describing excess and prolonged pain and inflammation that follows an injury to an arm or leg or any part of the body. CRPS is clinically characterized by sensory, autonomic, and motor disturbances; it can affect any part of the body, but occurs most often in the extremities. The wrist is most frequently affected after distal radial fractures. Complex regional pain syndrome can develop after different types of injuries, such as sprains and strains, surgeries, fractures, contusions, nerve lesions, stroke, etc.
&nbsp;
CRPS has acute (recent, short-term) and chronic (lasting greater than six months) forms. Besides the increased perception of pain, other signs and symptoms that are seen with CRPS, particularly in its early stages are a warm, red, and swollen extremity on the affected side. There are two types of CRPS, Type I occurs after an illness or injury that did not directly damage a nerve in the affected area, and Type II follows a distinct nerve injury. Although the triggers vary, both types of CRPS have the same symptoms and go through the same three stages of the disease. CRPS used to be known as reflex sympathetic dystrophy (RSD) (Type I) and causalgia (Type II). Type I comprises about 90 percent of all cases of CRPS.
&nbsp;
There are no objective diagnostic tests for CRPS. Since, its pathophysiologic basis of CRPS is not fully understood, mechanism-based diagnosis is not yet feasible. Therefore, the diagnosis of CRPS is based solely on clinical signs and symptoms. The actual diagnosis of CRPS is made solely based on history and physical examination to determine whether a patient meets CRPS diagnostic criteria (often called the Budapest criteria). Other than this, objective testing (thermography, triple-phase bone scan, quantitative sudomotor axon reflex test, or a trial sympathetic ganglion block) may be used to support a clinical diagnosis.
<h2>Complex Regional Pain Syndrome (CRPS) Epidemiology</h2>
The epidemiology section provides insights about the historical and current CRPS patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
&nbsp;
Key Findings
The disease epidemiology covered in the report provides a historical as well as forecasted CRPS epidemiology scenario in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034.
&nbsp;
In 2021, the total prevalent case of CRPS was ~318,500 cases in the 7MM, which are expected to grow during the study period, i.e., 2021-2034.
&nbsp;
The disease epidemiology covered in the report provides historical as well as forecasted CRPS epidemiology [segmented as Total Prevalent Cases of CRPS, Total Diagnosed Prevalent Cases of CRPS, Gender-specific Diagnosed Prevalent Cases of CRPS, Age-specific Diagnosed Prevalent Cases of CRPS, Type-specific Diagnosed Prevalent Cases of CRPS, Severity-Specific Diagnosed Prevalent Cases of CRPS, and Total treated cases of CRPS] in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034.
<h2>Country Wise- Complex Regional Pain Syndrome (CRPS) Epidemiology</h2>
The epidemiology segment also provides the CRPS epidemiology data and findings across the United States, EU4 and the United Kingdom, and Japan.
<h2>KOL- Views</h2>
To keep up with the current CRPS patient pool and forecasted trend, we take KOLs and SMEs ' opinions working in the CRPS domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.
<h2>Scope of the Report</h2>
<ul>
<li>The report covers the descriptive overview of CRPS, explaining its causes, symptoms, and pathophysiology.</li>
<li>The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU4 countries and the United Kingdom, and Japan.</li>
<li>The report assesses the disease risk and burden and highlights the unmet needs of CRPS.</li>
<li>The report helps to recognize the growth opportunities in the 7MM concerning the patient population.</li>
<li>The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of CRPS, Total Diagnosed Prevalent Cases of CRPS, Gender-specific Diagnosed Prevalent Cases of CRPS, Age-specific Diagnosed Prevalent Cases of CRPS, Type-specific Diagnosed Prevalent Cases of CRPS, Severity-Specific Diagnosed Prevalent Cases of CRPS, and Total treated cases of CRPS in the 7MM covering the United States, EU4 countries and the United Kingdom, and Japan from 2021 to 2034</li>
</ul>
<h2>Report Highlights</h2>
<ul>
<li>The companies and academics are working to assess challenges and seek opportunities that could influence CRPS R&amp;D. The therapies under development are focused on novel approaches to treat/improve the disease condition.</li>
<li>A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for CRPS.</li>
<li>Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.</li>
</ul>
<h2>Complex Regional Pain Syndrome (CRPS) Report Key Strengths</h2>
<ul>
<li>11 Years Forecast</li>
<li>7MM Coverage</li>
<li>CRPS Epidemiology Segmentation</li>
</ul>
<h2>Key Questions</h2>
Epidemiology Insights:
<ul>
<li>What are the disease risk, burden, and regional/ethnic differences of CRPS?</li>
<li>What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU4 and the United Kingdom, and Japan?</li>
<li>What is the historical CRPS patient pool in seven major markets covering the United States, EU4 and the United Kingdom, and Japan?</li>
<li>What would be the forecasted patient pool of CRPS in seven major markets covering the United States, EU4 and the United Kingdom, and Japan?</li>
<li>Where will be the growth opportunities in the 7MM concerning the patient population about CRPS?</li>
<li>Out of all 7MM countries, which country would have the highest prevalent population of CRPS during the forecast period (2025-2034)?</li>
<li>At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?</li>
</ul>
<h2>Reasons to buy</h2>
<ul>
<li>The report will help in developing business strategies by understanding trends shaping and driving the CRPS Disease market</li>
<li>To understand the future market competition in the CRPS Disease market</li>
<li>Organize sales and marketing efforts by identifying the best opportunities for CRPS Disease in the US, the EU4 and the UK, and Japan</li>
<li>Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors</li>
<li>Organize sales and marketing efforts by identifying the best opportunities for the CRPS Disease market</li>
<li>To understand the future market competition in the CRPS Disease market</li>
</ul>

1. Key Insights
2. Report Introduction
3. Complex Regional Pain Syndrome (CRPS) Market Overview at a Glance: By Class
3.1. Market Share (%) Distribution of CRPS in 2021
3.2. Market Share (%) Distribution of CRPS in 2034
4. Executive Summary of CRPS
4.1. Key Events
5. Epidemiology and Market Methodology
6. Disease Background and Overview
6.1. Introduction
6.2. Classification
6.3. Signs and Symptoms
6.4. Clinical Manifestations
6.5. Natural Course
6.5.1. Stages
6.6. Pathophysiology
7. Diagnosis of CRPS
7.1. Investigations
7.1.1. IASP Diagnostic Criteria
7.2. Imaging Techniques
7.3. Non-invasive imaging techniques
7.4. Thermography
7.5. Sudomotor Function Tests
7.6. Neurophysiological Tests
7.7. Examination
7.8. Differential diagnosis
7.9. Diagnostic Guidelines for CRPS
7.9.1. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition, 2022
7.9.2. UK guidelines for diagnosis, referral, and management in primary and secondary care for CRPS in adults
7.9.3. Japanese CRPS diagnostic criteria
8. Treatment and Management of CRPS
8.1. Treatment Guidelines
8.1.1. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition - the USA
8.1.2. UK guidelines for diagnosis, referral, and management in primary and secondary care for CRPS in adults
9. Epidemiology and Patient Population
9.1. Key Findings
9.2. Assumptions and Rationale
9.3. Epidemiology Scenario: 7MM
9.3.1. Total Prevalent Cases of CRPS in the 7MM
9.3.2. Total Diagnosed Prevalent cases of CRPS in the 7MM
9.3.3. Gender-specific Diagnosed Prevalent Cases of CRPS in the 7MM
9.3.4. Age-specific Diagnosed Prevalent Cases of CRPS in the 7MM
9.3.5. Type-specific Diagnosed Prevalent Cases of CRPS in the 7MM
9.3.6. Severity-specific Diagnosed Prevalent Cases of CRPS in the 7MM
9.3.7. Treated cases of CRPS in the 7MM
9.4. The United States Epidemiology
9.4.1. Total Prevalent Cases of CRPS in the United States
9.4.2. Total Diagnosed Prevalent cases of CRPS in the United States
9.4.3. Gender-specific Diagnosed Prevalent Cases of CRPS in the United States
9.4.4. Age-specific Diagnosed Prevalent Cases of CRPS in the United States
9.4.5. Type-specific Diagnosed Prevalent Cases of CRPS in the United States
9.4.6. Severity-specific Diagnosed Prevalent Cases of CRPS in the United States
9.4.7. Treated cases of CRPS in the US
9.5. EU4 and the UK Epidemiology
9.5.1. Total Prevalent Cases of CRPS in EU4 and the UK
9.5.2. Total Diagnosed Prevalent cases of CRPS in EU4 and the UK
9.5.3. Gender-specific Diagnosed Prevalent Cases of CRPS in EU4 and the UK
9.5.4. Age-specific Diagnosed Prevalent Cases of CRPS in EU4 and the UK
9.5.5. Type-specific Diagnosed Prevalent Cases of CRPS in EU4 and the UK
9.5.6. Severity-specific Diagnosed Prevalent Cases of CRPS in EU4 and the UK
9.5.7. Treated cases of CRPS in EU4 and the UK
9.6. Japan Epidemiology
9.6.1. Total Prevalent Cases of CRPS in Japan
9.6.2. Total Diagnosed Prevalent cases of CRPS in Japan
9.6.3. Gender-specific Diagnosed Prevalent Cases of CRPS in Japan
9.6.4. Age-specific Diagnosed Prevalent Cases of CRPS in Japan
9.6.5. Type-specific Diagnosed Prevalent Cases of CRPS in Japan
9.6.6. Severity-specific Diagnosed Prevalent Cases of CRPS in Japan
9.6.7. Treated cases of CRPS in Japan
10. Unmet Needs
11. Appendix
11.1. Bibliography
11.2. Acronyms and Abbreviations
11.3. Report Methodology
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

DelveInsight's "Complex Regional Pain Syndrome (CRPS) - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Complex Regional Pain Syndrome (CRPS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Complex Regional Pain Syndrome Epidemiology

Complex Regional Pain Syndrome (CRPS) - Epidemiology Forecast - 2034

DelveInsight's Complex Regional Pain Syndrome (CRPS) - Epidemiology Forecast 2034 report delivers an in-depth understanding of the disease, historical, and forecasted